Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
about
Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virusCBD binding domain fused γ-lactamase from Sulfolobus solfataricus is an efficient catalyst for (-) γ-lactam productionInfluenza A virus neuraminidase limits viral superinfectionCurrent and future antiviral therapy of severe seasonal and avian influenzaPeramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza InfectionsRole of Marine Natural Products in the Genesis of Antiviral AgentsSafety and efficacy of peramivir for influenza treatmentInduced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor bindingStructural basis for a class of nanomolar influenza A neuraminidase inhibitorsPeramivir (BCX-1812, RWJ-270201): potential new therapy for influenzaEfficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza virusesDetection of the antiviral drug oseltamivir in aquatic environmentsImpact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling studyResistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.Japanese Surveillance Systems and Treatment for Influenza.The pharmacological management of severe influenza infection - 'existing and emerging therapies'.New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors.Novel strategies for prevention and treatment of influenza.Antiviral therapy of influenza.One-bead-one-inhibitor-one-substrate screening of neuraminidase activity.Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations.Zanamivir-resistant influenza viruses with a novel neuraminidase mutationOseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in JapanRapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hostsPeramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.OpenFluDB, a database for human and animal influenza virus.Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A virusesDetection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birdsAntiviral strategies for pandemic and seasonal influenzaEfficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infectionPeramivir for the treatment of influenza.Harnessing DNA synthesis to develop rapid responses to emerging and pandemic pathogens.Adapting global influenza management strategies to address emerging viruses.Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitorsNeuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.
P2860
Q21144425-5236BA94-9689-4097-867A-54D854048666Q21256669-B2FE1FFB-6F70-4336-BBEE-F675EEEEF8E4Q24656050-DD454BE9-C741-47C6-8A41-3BCFF9C86027Q24656164-6CA753F8-F67F-44A6-807F-2CDDCC015360Q26749578-6F37A481-24CC-4E90-BA90-4B1E5D9823C8Q26796360-457F983E-7F5D-475A-88A4-0D85730D2FDEQ27027408-7B326D5A-BD10-40FD-85E4-360EEBFF8A6FQ27677074-A1848778-7F63-4489-A927-F174DA22D7D3Q27680378-9811C8AB-A4A3-42B7-AB32-5120A23804C8Q28201381-9306E63C-92A1-461E-9A60-A1C82DED8EF8Q28473051-9FE9DC69-D8D1-4FB0-8A18-2D343328333BQ28475674-B8D9BA12-FE91-4C2E-8514-A2E7362CA035Q28537982-A0A36387-1D4D-46AB-877B-E7AA2BEF50D5Q30151772-55B3E30B-3AB8-4561-BD44-3FC73EAACAA7Q30228322-AD066B79-620C-4810-B40D-95E0F5ABAC2DQ30239895-48ECE18B-1990-439B-A02F-F31B5F8A04AFQ30243907-29C0CAA6-BF9A-4073-A4CB-8B8075880B62Q30332341-D8D111D8-6D46-4937-BFF8-7C6763644DDAQ30350342-47822913-1592-4115-9240-016181BA916BQ30350565-86FA46CD-3277-428E-B003-695EC6C0CBA2Q30351369-5071E3E9-58B1-4D88-B6C5-EB86059E0FEBQ30364619-76D8711C-6ADC-415C-8EB7-F70D2A162018Q30375636-68ABA272-E74B-458F-91F4-6E1EDCE73502Q30379353-F3A48D0A-D1C3-4394-BA66-D6E43E7AB5ECQ30384168-B1734813-DC4B-4F5B-B4D0-84AB16DB4AF4Q30387332-6BD959BE-8EBC-4A98-8083-0C0FF028556AQ30389887-28B29EC3-96F1-4869-BE19-99AAE7BFACE3Q30390145-ADB087FF-40B0-4EAD-B50C-F81F1C84B9C8Q30390818-3DE3507C-C631-4A35-BB75-AD63386C9B7CQ30391319-3931CE39-3E9E-427A-9EE8-DE0521EF485EQ30391856-F7C59EF2-06EF-486D-8852-33D64075D2BCQ30394067-D4FCE80B-4721-46B7-BF60-3A0A5F14A868Q30398804-C2744748-56D6-4155-ABF7-62F821BD2E48Q30408116-4CDCCBCC-5A3F-4369-A843-FB2330DC7070Q30408582-6F3C0FE0-BB5D-4BA8-B2B2-0B5D6E695BF2Q30413154-BBD16266-13E2-4B0A-ACEB-FBDD4CA2C269Q30428799-8A7C48A3-CEB5-4A46-A7B0-37A60C99CC83Q30431093-5D38749D-292E-4CD1-A2C8-62E224FDB62AQ30450742-9DCFC394-E146-49B0-9CA6-7E21F4428CEEQ30452889-0418959E-DCA0-4A72-B04F-CABD2DAE0A32
P2860
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Comparison of the activities o ...... e inhibitor-resistant variants
@nl
Comparison of the activities o ...... inhibitor-resistant variants.
@ast
Comparison of the activities o ...... inhibitor-resistant variants.
@en
type
label
Comparison of the activities o ...... e inhibitor-resistant variants
@nl
Comparison of the activities o ...... inhibitor-resistant variants.
@ast
Comparison of the activities o ...... inhibitor-resistant variants.
@en
prefLabel
Comparison of the activities o ...... e inhibitor-resistant variants
@nl
Comparison of the activities o ...... inhibitor-resistant variants.
@ast
Comparison of the activities o ...... inhibitor-resistant variants.
@en
P2860
P3181
P1476
Comparison of the activities o ...... inhibitor-resistant variants.
@en
P2093
F G Hayden
L V Gubareva
P2860
P304
P3181
P356
10.1128/AAC.45.12.3403-3408.2001
P407
P577
2001-12-01T00:00:00Z